Publication | Closed Access

Bioisosteric replacement of dihydropyrazole of 4S-(−)-3-(4-chlorophenyl)-N-methyl-N′-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole

Bioisosteric ReplacementMolecular PharmacologyBioorganic ChemistryBiochemistryMedicineNatural SciencesPharmacological AgentPharmacotherapyHeterocycle ChemistryDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug Discovery